Patients with diabetes who are at risk of diabetic retinopathy (DR) experience a two-fold increase in the risk of developing DR or experiencing a progression of their retinopathy within one year of phacoemulsification (“phaco”) cataract surgery, according to the results of a recent Australian study.
